- Home
- OM vs FLC Comparison
OM vs FLC Comparison
Compare OM & FLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OM
- FLC
- Stock Information
- Founded
- OM 2003
- FLC 2003
- Country
- OM United States
- FLC United States
- Employees
- OM N/A
- FLC N/A
- Industry
- OM Biotechnology: Electromedical & Electrotherapeutic Apparatus
- FLC Trusts Except Educational Religious and Charitable
- Sector
- OM Health Care
- FLC Finance
- Exchange
- OM Nasdaq
- FLC Nasdaq
- Market Cap
- OM 233.1M
- FLC 186.8M
- IPO Year
- OM 2020
- FLC N/A
- Fundamental
- Price
- OM $4.67
- FLC $17.61
- Analyst Decision
- OM Strong Buy
- FLC
- Analyst Count
- OM 3
- FLC 0
- Target Price
- OM $16.00
- FLC N/A
- AVG Volume (30 Days)
- OM 618.9K
- FLC 37.8K
- Earning Date
- OM 11-10-2025
- FLC 01-01-0001
- Dividend Yield
- OM N/A
- FLC 6.64%
- EPS Growth
- OM N/A
- FLC N/A
- EPS
- OM N/A
- FLC N/A
- Revenue
- OM $120,069,000.00
- FLC N/A
- Revenue This Year
- OM $12.46
- FLC N/A
- Revenue Next Year
- OM $10.51
- FLC N/A
- P/E Ratio
- OM N/A
- FLC N/A
- Revenue Growth
- OM 4.65
- FLC N/A
- 52 Week Low
- OM $4.53
- FLC $12.62
- 52 Week High
- OM $25.35
- FLC $15.45
- Technical
- Relative Strength Index (RSI)
- OM 15.45
- FLC 43.35
- Support Level
- OM $11.41
- FLC $17.52
- Resistance Level
- OM $12.47
- FLC $17.72
- Average True Range (ATR)
- OM 0.82
- FLC 0.13
- MACD
- OM -0.97
- FLC -0.01
- Stochastic Oscillator
- OM 1.41
- FLC 26.67
About OM Outset Medical Inc.
Outset Medical Inc is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.
About FLC Flaherty & Crumrine Total Return Fund Inc
Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.